As Americans enroll in their plan of choice for 2025, it’s vital for policymakers in both parties to support and strengthen workplace coverage for years to come. Thanks to robust competition among...

Hospital service prices have surged more than 220% from 2000 to 2022, significantly outpacing inflation and price increases for other medical services. The rise is largely attributed to increased...

An analysis of medical claims data from 50 million adults with commercial insurance found that transitioning care from in-person to virtual could lower overall medical claims spending by 2.3% to...

With the rising popularity of GLP-1 weight-loss drugs, more employers are evaluating coverage options despite the high costs. The financial strain of covering these medications is leading some...

Due to rising drug prices, US spending on cancer medications is expected to jump to $180 billion by 2028. Last year, Americans spent $99 billion on clinician-administered and oral cancer drugs,...

About 8 in 10 respondents to a KFF survey think the cost of prescription medicines are unreasonable and that the profits made by drugmakers are a significant factor in drug prices. According to the...